Literature DB >> 3056728

The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.

D Worth1, J Harvey, J Brown, M Lee.   

Abstract

L-dopa 7 micrograms.kg-1.min-1 was given intravenously over 2 h to six healthy subjects, controlled by an infusion of saline on a separate occasion, with measurement of plasma renin activity (PRA), urinary sodium and potassium excretion, effective renal plasma flow (ERPF), glomerular filtration rate (GFR), blood pressure, and pulse rate. Mean PRA fell by 50% following L-dopa, which was significantly different from the slight rise which occurred after saline infusion. There was a significant increase in urinary sodium excretion and effective renal plasma flow on infusion of L-dopa. Mean diastolic blood pressure fell during L-dopa infusion, in contrast to the slight increase which occurred during the control study. These observations confirm the anticipated renal dopaminergic effects of L-dopa and also suggest a dopaminergic influence on renin release in man.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056728     DOI: 10.1007/bf00609242

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  33 in total

1.  Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.

Authors:  D P Worth; J N Harvey; J Brown; A Worral; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

2.  Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney.

Authors:  R J Dinerstein; J Vannice; R C Henderson; L J Roth; L I Goldberg; P C Hoffmann
Journal:  Science       Date:  1979-08-03       Impact factor: 47.728

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects.

Authors:  D P Worth; J N Harvey; J Brown; M R Lee
Journal:  Clin Sci (Lond)       Date:  1985-08       Impact factor: 6.124

5.  Production of urine free dopamine from DOPA; a micropuncture study.

Authors:  A D Baines; W Chan
Journal:  Life Sci       Date:  1980-01-28       Impact factor: 5.037

6.  Tubular secretion and metabolism of dopamine, norepinephrine, methoxytyramine and normetanephrine by the rat kidney.

Authors:  A D Baines; A Craan; W Chan; N Morgunov
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

7.  Dopaminergic modulation of the renal effect of arginine-vasopressin in water-loaded rats.

Authors:  S Koyama; M Sasaki; T Setoyama; K Takahashi; K Togashi; K Suzuki; N Kakki; M Imai
Journal:  Jpn J Pharmacol       Date:  1985-05

8.  Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa.

Authors:  J Hagege; G Richet
Journal:  Kidney Int       Date:  1985-01       Impact factor: 10.612

9.  (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.

Authors:  T M MacDonald; R F Jeffrey; S Freestone; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

10.  The diuretic properties of dopamine in patients after open-heart operation.

Authors:  M Hilberman; J Maseda; E B Stinson; G C Derby; R J Spencer; D C Miller; P E Oyer; B D Myers
Journal:  Anesthesiology       Date:  1984-11       Impact factor: 7.892

View more
  3 in total

1.  An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion.

Authors:  Emily M Garland; Tericka S Cesar; Suzanna Lonce; Marcus C Ferguson; David Robertson
Journal:  Am J Clin Nutr       Date:  2013-04-03       Impact factor: 7.045

Review 2.  Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease.

Authors:  Giulio Scigliano; Gabriele Ronchetti; Floriano Girotti
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307

Review 3.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.